These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22043333)

  • 21. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor.
    Carlsson K; Freskgård PO; Persson E; Carlsson U; Svensson M
    Eur J Biochem; 2003 Jun; 270(12):2576-82. PubMed ID: 12787023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls.
    Blann AD; Amiral J; McCollum CN; Lip GY
    Atherosclerosis; 2000 Sep; 152(1):29-34. PubMed ID: 10996336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
    Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue factor, its pathway inhibitor, and metabolic disturbances in long-term peritoneal dialysis.
    Zemanová P; Opatrný K; Opatrná S; Vít L; Sefrna F; Racek J
    Kidney Blood Press Res; 2003; 26(5-6):368-75. PubMed ID: 14610342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postprandial factor VII activation does not increase plasma concentrations of prothrombin fragment 1 + 2 in patients with morbid obesity.
    Landgrebe LE; Juhl CB; Andersen V; Moitinho-Silva L; Bang C; Bladbjerg EM
    Thromb Res; 2020 Dec; 196():260-267. PubMed ID: 32920297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue factor pathway inhibitor: structure, biology and involvement in disease.
    Lwaleed BA; Bass PS
    J Pathol; 2006 Feb; 208(3):327-39. PubMed ID: 16261634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
    Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
    Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
    Kario K; Miyata T; Sakata T; Matsuo T; Kato H
    Arterioscler Thromb; 1994 Feb; 14(2):265-74. PubMed ID: 8305419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
    Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
    Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation.
    Spiezia L; Campello E; Valle FD; Woodhams B; Simioni P
    Clin Chem Lab Med; 2017 Mar; 55(4):484-488. PubMed ID: 27522621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.
    Stavik B; Tinholt M; Sletten M; Skretting G; Sandset PM; Iversen N
    J Hematol Oncol; 2013 Jan; 6():5. PubMed ID: 23320987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI.
    Henriquez S; Calderon C; Quezada M; Oliva B; Bravo ML; Aranda E; Kato S; Cuello MA; Gutiérrez J; Quest AF; Owen GI
    J Cell Physiol; 2011 Dec; 226(12):3278-85. PubMed ID: 21344386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes of tissue factor and tissue factor pathway inhibitor in neonatal jaundice due to infection].
    Yue SJ; Zhong L; He XF; Yang YJ; Jiang L; He SL; Li JC
    Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):104-6. PubMed ID: 14759309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease.
    Key NS; Slungaard A; Dandelet L; Nelson SC; Moertel C; Styles LA; Kuypers FA; Bach RR
    Blood; 1998 Jun; 91(11):4216-23. PubMed ID: 9596669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.
    Kario K; Matsuo T; Kobayashi H; Matsuo M; Sakata T; Miyata T
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1114-20. PubMed ID: 7627704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.
    Erez O; Romero R; Vaisbuch E; Kusanovic JP; Mazaki-Tovi S; Chaiworapongsa T; Gotsch F; Fareed J; Hoppensteadt D; Than NG; Yoon BH; Edwin S; Dong Z; Espinoza J; Mazor M; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Jan; 23(1):23-33. PubMed ID: 19883261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein.
    Hamik A; Setiadi H; Bu G; McEver RP; Morrissey JH
    J Biol Chem; 1999 Feb; 274(8):4962-9. PubMed ID: 9988740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue factor-expressing tumor cells can bind to immobilized recombinant tissue factor pathway inhibitor under static and shear conditions in vitro.
    Che SP; DeLeonardis C; Shuler ML; Stokol T
    PLoS One; 2015; 10(4):e0123717. PubMed ID: 25849335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.